Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Invested Capital (2010 - 2017)

Exelixis (EXEL) posted quarterly Invested Capital of $113.3 million for Q1 2017, up 312.18% year-over-year from $27.5 million in Q1 2016, and up 3.87% quarter-over-quarter from $109.1 million in Q4 2016.

Analysis

Exelixis (EXEL) Invested Capital (2010 - 2017) Analysis & Trends

Exelixis' Invested Capital history runs 8 years deep, the most recent figure standing at $113.3 million for Q1 2017.

  • In Q1 2017, Invested Capital rose 312.18% year-over-year to $113.3 million; the TTM figure through Dec 2017 stood at $113.3 million (down 41.42% YoY), while the FY2016 annual figure was $109.1 million, changed N/A from the prior year.
  • Invested Capital for Q1 2017 stood at $113.3 million, up from $109.1 million in the prior quarter.
  • The five-year high for Invested Capital was $113.3 million in Q1 2017, with the low at $450000.0 in Q3 2015.
  • The 5-year median for Invested Capital is $27.5 million (2016), against an average of $45.7 million.
  • The sharpest annual moves came in 2015 and 2016: Invested Capital tumbled 99.53% in 2015, then surged 6425.56% in 2016.
  • Exelixis' Invested Capital stood at $10.0 million in 2013, then soared by 874.49% to $97.4 million in 2014, then slumped by 99.54% to $450000.0 in 2015, then soared by 24149.33% to $109.1 million in 2016, then climbed by 3.87% to $113.3 million in 2017.
  • Business Quant data shows EXEL's Invested Capital at $113.3 million in Q1 2017, $109.1 million in Q4 2016, and $29.4 million in Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 29, 2017 284.96 Mn
Jun 30, 2017 148.51 Mn
Mar 31, 2017 233.10 Mn
Dec 30, 2016 278.44 Mn
Sep 30, 2016 141.39 Mn
Jun 30, 2016 -78.63 Mn
Mar 31, 2016 -48.45 Mn
Dec 31, 2015 -60.81 Mn
Sep 30, 2015 6.22 Mn
Jun 30, 2015 -108.19 Mn
Mar 31, 2015 -62.68 Mn
Dec 31, 2014 18.51 Mn
Sep 30, 2014 118.74 Mn
Jun 30, 2014 178.58 Mn
Mar 31, 2014 153.09 Mn
Dec 31, 2013 106.59 Mn
Sep 30, 2013 225.65 Mn
Jun 30, 2013 290.01 Mn
Mar 31, 2013 349.32 Mn
Dec 31, 2012 333.39 Mn